Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals Market Cap: 2.315B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 2.315B |
May 16, 2024 | 2.388B |
May 15, 2024 | 2.415B |
May 14, 2024 | 2.462B |
May 13, 2024 | 2.451B |
May 10, 2024 | 2.386B |
May 09, 2024 | 2.347B |
May 08, 2024 | 2.373B |
May 07, 2024 | 2.399B |
May 06, 2024 | 2.675B |
May 03, 2024 | 2.668B |
May 02, 2024 | 2.499B |
May 01, 2024 | 2.526B |
April 30, 2024 | 2.424B |
April 29, 2024 | 2.367B |
April 26, 2024 | 2.334B |
April 25, 2024 | 2.326B |
April 24, 2024 | 2.421B |
April 23, 2024 | 2.439B |
April 22, 2024 | 2.379B |
April 19, 2024 | 2.317B |
April 18, 2024 | 2.323B |
April 17, 2024 | 2.344B |
April 16, 2024 | 2.348B |
April 15, 2024 | 2.444B |
Date | Value |
---|---|
April 12, 2024 | 2.459B |
April 11, 2024 | 2.596B |
April 10, 2024 | 2.506B |
April 09, 2024 | 2.659B |
April 08, 2024 | 2.548B |
April 05, 2024 | 2.472B |
April 04, 2024 | 2.445B |
April 03, 2024 | 2.493B |
April 02, 2024 | 2.442B |
April 01, 2024 | 2.602B |
March 28, 2024 | 2.606B |
March 27, 2024 | 2.513B |
March 26, 2024 | 2.377B |
March 25, 2024 | 2.385B |
March 22, 2024 | 2.439B |
March 21, 2024 | 2.444B |
March 20, 2024 | 2.386B |
March 19, 2024 | 2.353B |
March 18, 2024 | 2.442B |
March 15, 2024 | 2.406B |
March 14, 2024 | 2.407B |
March 13, 2024 | 2.464B |
March 12, 2024 | 2.416B |
March 11, 2024 | 2.436B |
March 08, 2024 | 2.522B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Pfizer Inc | 162.29B |
Amicus Therapeutics Inc | 2.835B |
Insmed Inc | 3.681B |
Altimmune Inc | 567.57M |
Regeneron Pharmaceuticals Inc | 108.23B |
Market Cap Related Metrics
PS Ratio | 24.17 |
PEG Ratio | -0.2146 |
Price to Book Value | 37.59 |
Price | 37.99 |
Earnings Yield | -12.20% |
PEGY Ratio | -0.2146 |